US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Neuroscience and Healthcare ETF

31.39

-0.4722-1.48%

Volume:321

Turnover:10.16K

Market Cap:6.28M

PE:- -

High:31.72

Open:31.72

Low:31.39

Close:31.87

52wk High:43.01

52wk Low:27.40

Shares:200.00K

Float Shares:200.00K

Volume Ratio:0.15

T/O Rate:0.16%

Dividend:0.32

Dividend Rate:1.01%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

With the World's First Brain-Computer Interface Approval in Hand, How Far Is Neuracle From Profitability?

Scholar Rock Resubmits Apitegromab MAA to EMA for SMA Treatment

Scholar Rock Holding Corporation - Anticipates Chmp Opinion on Apitegromab Maa in H1 2027

THOMSON REUTERS

Scholar Rock Resubmits Apitegromab Marketing Authorisation Application (Maa) to European Medicines Agency (Ema) for Treatment of Children and Adults with Spinal Muscular Atrophy (Sma)

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/IBRN"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IBRN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBRN\",,,,,undefined,":{"symbol":"IBRN","market":"US","secType":"STK","nameCN":"iShares Neuroscience and Healthcare ETF","latestPrice":31.3928,"timestamp":1791489600000,"preClose":31.865,"halted":0,"volume":321,"delay":0,"changeRate":-0.014818766671896981,"floatShares":200000,"shares":200000,"eps":0,"marketStatus":"Pre-Mkt","change":-0.4722,"latestTime":"10-09 05:31:08 EDT","open":31.72,"high":31.72,"low":31.3928,"amount":10162,"amplitude":0.010268,"askPrice":49.91,"askSize":100,"bidPrice":30.03,"bidSize":4,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791552600000},"marketStatusCode":1,"adr":0,"exchange":"ARCA","adjPreClose":31.3928,"sharesOutstanding":150000,"nav":31.865918,"aum":6373183.6,"dividendRate":0.010149,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":31.72,"preClose":31.3928,"latestTime":"16:10 EDT","volume":6,"amount":188.2912,"timestamp":1791490204224,"change":0.3272,"changeRate":0.010423,"amplitude":0},"volumeRatio":0.14874885048069997,"impliedVol":0.0879,"impliedVolPercentile":0.528},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBRN\",,,,,undefined,":{"symbol":"IBRN","floatShares":200000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.14874885048069997,"shares":200000,"dividePrice":0.3186,"high":31.72,"amplitude":0.010268,"preClose":31.865,"low":31.3928,"week52Low":27.4025,"pbRate":"--","week52High":43.01,"institutionHeld":0,"latestPrice":31.3928,"committee":-0.923077,"eps":0,"divideRate":0.010149,"volume":321,"delay":0,"ttmEps":0,"open":31.72,"prevYearClose":32.3193,"prevWeekClose":32.552,"prevMonthClose":33.265,"prevQuarterClose":33.265,"fiveDayClose":32.8651,"twentyDayClose":37.33,"sixtyDayClose":38.0334},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBRN\",params:#limit:5,,,undefined,":[{"date":"2025-12-16","symbol":"IBRN","amount":0.319807,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"iShares Neuroscience and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2024-12-17","symbol":"IBRN","amount":0.10114,"announcedDate":"2024-12-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"iShares Neuroscience and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-20","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-20"},{"date":"2023-12-20","symbol":"IBRN","amount":0.006303,"announcedDate":"2023-12-19","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"iShares Neuroscience and Healthcare ETF","recordDate":"2023-12-27","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-27"},{"date":"2023-06-07","symbol":"IBRN","amount":0.008241,"announcedDate":"2023-05-12","type":"dividend","market":"US","newRecordDate":"2023-06-08","defaultRemindTime":1686144600000,"name":"iShares Neuroscience and Healthcare ETF","recordDate":"2023-06-13","payableDate":"2023-06-08","currency":"USD","dateTimestamp":1686110400000,"payDate":"2023-06-13"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBRN\",market:\"US\",,,undefined,":[{"executeDate":"2023-06-07","recordDate":"2023-06-08","paymentDate":"2023-06-13","value":0.008241,"currency":"USD"},{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-27","value":0.006303,"currency":"USD"},{"executeDate":"2024-12-17","recordDate":"2024-12-17","paymentDate":"2024-12-20","value":0.10114,"currency":"USD"},{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-19","value":0.319807,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBRN\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBRN\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1150577208","title":"With the World's First Brain-Computer Interface Approval in Hand, How Far Is Neuracle From Profitability?","url":"https://stock-news.laohu8.com/highlight/detail?id=1150577208","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150577208?lang=en_us&edition=fundamental","pubTime":"2026-10-08 21:02","pubTimestamp":1791464577,"startTime":"0","endTime":"0","summary":"On September 29, Neuracle, a leading player in China's brain-computer interface sector, updated its prospectus for a STAR Market IPO. According to the latest financial data disclosed by the company,...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRN","IPOS","MNTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673074028","title":"Scholar Rock Resubmits Apitegromab MAA to EMA for SMA Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2673074028","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673074028?lang=en_us&edition=fundamental","pubTime":"2026-10-08 20:05","pubTimestamp":1791461130,"startTime":"0","endTime":"0","summary":"Scholar Rock resubmits apitegromab MAA to EMA for SMA treatmentScholar Rock resubmitted its EMA marketing authorization application for apitegromab to treat children and adults with spinal muscular at","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261008:nNDL87NWDn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","THNR","SRRK","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673747750","title":"Scholar Rock Holding Corporation - Anticipates Chmp Opinion on Apitegromab Maa in H1 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2673747750","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673747750?lang=en_us&edition=fundamental","pubTime":"2026-10-08 20:00","pubTimestamp":1791460803,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261008:nTUA29VWNX:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBRN","BK4139","THNR","SRRK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673744880","title":"Scholar Rock Resubmits Apitegromab Marketing Authorisation Application (Maa) to European Medicines Agency (Ema) for Treatment of Children and Adults with Spinal Muscular Atrophy (Sma)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673744880","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673744880?lang=en_us&edition=fundamental","pubTime":"2026-10-08 20:00","pubTimestamp":1791460803,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261008:nTUA29VWNX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SRRK","IBRN","BK4139","THNR"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":50,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/IBRN\",params:#limit:6,delay:false,,,undefined,":[]}}